» Articles » PMID: 35981509

Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated Across a Broad PH Range

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2022 Aug 18
PMID 35981509
Authors
Affiliations
Soon will be listed here.
Abstract

Cathepsin B is a lysosomal protease that participates in protein degradation. However, cathepsin B is also active under neutral pH conditions of the cytosol, nuclei, and extracellular locations. The dipeptidyl carboxypeptidase (DPCP) activity of cathepsin B, assayed with the Abz-GIVR↓AK(Dnp)-OH substrate, has been reported to display an acidic pH optimum. In contrast, the endopeptidase activity, monitored with Z-RR-↓AMC, has a neutral pH optimum. These observations raise the question of whether other substrates can demonstrate cathepsin B DPCP activity at neutral pH and endopeptidase activity at acidic pH. To address this question, global cleavage profiling of cathepsin B with a diverse peptide library was conducted under acidic and neutral pH conditions. Results revealed that cathepsin B has (1) major DPCP activity and modest endopeptidase activity under both acidic and neutral pH conditions and (2) distinct pH-dependent amino acid preferences adjacent to cleavage sites for both DPCP and endopeptidase activities. The pH-dependent cleavage preferences were utilized to design a new Abz-GVR↓AK(Dnp)-OH DPCP substrate, with norleucine (n) at the P3 position, having improved DPCP activity of cathepsin B at neutral pH compared to the original Abz-GIVR↓AK(Dnp)-OH substrate. The new Z-VR-AMC and Z-ER-AMC substrates displayed improved endopeptidase activity at acidic pH compared to the original Z-RR-AMC. These findings illustrate the new concept that cathepsin B possesses DPCP and endopeptidase activities at both acidic and neutral pH values. These results advance understanding of the pH-dependent cleavage properties of the dual DPCP and endopeptidase activities of cathepsin B that function under different cellular pH conditions.

Citing Articles

Muscle-brain crosstalk mediated by exercise-induced myokines - insights from experimental studies.

Kostka M, Morys J, Malecki A, Nowacka-Chmielewska M Front Physiol. 2024; 15:1488375.

PMID: 39687518 PMC: 11647023. DOI: 10.3389/fphys.2024.1488375.


Expanding the Library of Covalent Cysteine Cathepsin Probes Featuring Sulfoxonium Ylide Electrophiles.

Xu B, Mountford S, Thompson P, Edgington-Mitchell L ACS Omega. 2024; 9(43):43940-43947.

PMID: 39494001 PMC: 11525741. DOI: 10.1021/acsomega.4c07604.


Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis.

Gallwitz L, Bleibaum F, Voss M, Schweizer M, Spengler K, Winter D Cell Mol Life Sci. 2024; 81(1):227.

PMID: 38775843 PMC: 11111660. DOI: 10.1007/s00018-024-05274-4.


Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate.

Xu B, Anderson B, Mountford S, Thompson P, Mintern J, Edgington-Mitchell L Biol Chem. 2024; 405(5):351-365.

PMID: 38410910 DOI: 10.1515/hsz-2023-0355.


Atg4B and Cathepsin B-Triggered in Situ Luciferin Formation for Precise Cancer Autophagy Bioluminescence Imaging.

Cheng X, Xia T, Sun X, Liang G, Liu X, Liang G ACS Cent Sci. 2024; 9(12):2251-2256.

PMID: 38161373 PMC: 10755845. DOI: 10.1021/acscentsci.3c00696.


References
1.
Yamamoto A, Hara T, Tomoo K, Ishida T, Fujii T, Hata Y . Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex. J Biochem. 1997; 121(5):974-7. DOI: 10.1093/oxfordjournals.jbchem.a021682. View

2.
Almeida P, Nantes I, Chagas J, Rizzi C, Faljoni-Alario A, Carmona E . Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem. 2000; 276(2):944-51. DOI: 10.1074/jbc.M003820200. View

3.
Spizz G, Blackshear P . Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme. J Biol Chem. 1997; 272(38):23833-42. DOI: 10.1074/jbc.272.38.23833. View

4.
Cavallo-Medved D, Dosescu J, Linebaugh B, Sameni M, Rudy D, Sloane B . Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. Neoplasia. 2004; 5(6):507-19. PMC: 1502576. DOI: 10.1016/s1476-5586(03)80035-0. View

5.
KIRSCHKE H, Langner J, Riemann S, Wiederanders B, Ansorge S, Bohley P . Lysosomal cysteine proteinases. Ciba Found Symp. 1979; (75):15-35. DOI: 10.1002/9780470720585.ch2. View